NRX Pharmaceuticals's top three insider shareholders as of April 28, 2026 are Jonathan C Javitt (Director, 12.90Mn shares), Daniel C. Javitt (TenPercentOwner, 9.87Mn shares), Daniel C. Javitt (TenPercentOwner, 9.63Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Jonathan C Javitt | - | 0 | 12,899,997 | 09 Dec, 2022 |
| Daniel C. Javitt | - | 0 | 9,872,901 | 02 Aug, 2022 |
| Daniel C. Javitt | - | 0 | 9,634,793 | 01 Dec, 2022 |
| Chaim Hurvitz | - | 570,000 | 0 | 11 Sep, 2023 |
| Chaim Hurvitz | - | 500,000 | 0 | 23 Nov, 2022 |
| Aaron Gorovitz | - | 0 | 105,000 | 11 Sep, 2023 |
| Jonathan C Javitt | Chairman And Chief Scientist | 84,634 | 0 | 17 Dec, 2024 |
| Stephen H Willard | Chief Executive Officer | 50,000 | 0 | 18 Dec, 2022 |
| Voorhees Seth Van | Chief Financial Officer | 46,337 | 0 | 18 Dec, 2022 |
| Patrick John Flynn | - | 1,750 | 40,209 | 28 Nov, 2022 |
| Alessandra Daigneault | General Counsel Secretary | 31,584 | 0 | 02 Nov, 2021 |
| Herbert Raymond Mcmaster | - | 18,300 | 0 | 02 Nov, 2021 |
| Voorhees Seth Van | Chief Financial Officer | 0 | 16,377 | 28 Nov, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 27 Jan, 2026 | Joseph Michael Casper | Stock Option (right to buy) | A | 100,000 | $0.00 | 100,000 | D | A |
| 07 Feb, 2025 | Michael S Abrams | Stock Option (right to buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 17 Dec, 2024 | Jonathan C Javitt | Common Stock | A | 40,000 | $1.17 | 84,634 | D | P |
| 30 Aug, 2023 | Chaim Hurvitz | Common Stock, par value $0.001 per share | A | 70,000 | $0.29 | 570,000 | D | P |
| 30 Aug, 2023 | Aaron Gorovitz | Common Stock, par value $0.001 per share | A | 35,000 | $0.32 | 105,000 | I | P |
| 23 Aug, 2023 | Jonathan C Javitt | Common Stock | A | 100,000 | $0.33 | 446,332 | D | P |
| 22 Aug, 2023 | Jonathan C Javitt | Common Stock | A | 200,000 | $0.32 | 346,332 | D | P |
| 16 Dec, 2022 | Stephen H Willard | Common Stock, par value $0.001 per share | A | 50,000 | $1.17 | 50,000 | D | P |
| 25 Nov, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 8,716 | $1.12 | 8,716 | D | P |
| 16 Dec, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 30,000 | $1.10 | 46,337 | D | P |
| 25 Nov, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 600 | $1.10 | 9,316 | D | P |
| 25 Nov, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 7,021 | $1.11 | 16,337 | D | P |
| 07 Dec, 2022 | Jonathan C Javitt | Common Stock, par value $0.001 per share | D | 400,000 | $1.00 | 12,899,997 | I | S |
| 29 Nov, 2022 | Daniel C. Javitt | common stock | D | 13,730 | $1.50 | 9,643,234 | I | S |
| 30 Nov, 2022 | Daniel C. Javitt | common stock | D | 8,441 | $1.50 | 9,634,793 | I | S |
| 25 Nov, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 8,716 | $1.12 | 8,716 | I | P |
| 28 Nov, 2022 | Patrick John Flynn | Common Stock, par value $0.001 per share | A | 2,500 | $1.25 | 37,709 | I | P |
| 25 Nov, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 600 | $1.10 | 9,316 | I | P |
| 28 Nov, 2022 | Patrick John Flynn | Common Stock, par value $0.001 per share | A | 2,500 | $1.25 | 40,209 | I | P |
| 25 Nov, 2022 | Voorhees Seth Van | Common Stock, par value $0.001 per share | A | 7,021 | $1.11 | 16,377 | I | P |